logo nano spa 1
  • Cabecera 1
    nanoscience and nanotechnology: small is different
  • Home
  • Research
  • Projects
  • 2017
  • NOCANTHER Nanomedicine upscaling for early clinical phases of multimodal cancer therapy

NOCANTHER Nanomedicine upscaling for early clinical phases of multimodal cancer therapy

Prof. Rodolfo Miranda (PI), Dr. Alvaro Somoza (PI)

NOCANTHER  Nanomedicine upscaling for early clinical phases of multimodal cancer therapy
    Funding : H2020-NMP-2015-two-stage no 685795
    Duration: 2016 - 2021
    60 months

The NoCanTher consortium aims to scale-up a magnetic nanoparticle formulation based on iron oxide and assess it in a clinical study for the treatment of pancreatic cancer with an alternating magnetic field generator. The combination of the particles and the magnetic field at the tumoral area will increase the temperature inducing the death of tumoral cells. This process is known as magnetic hyperthermia where, remarkably, cancer cells are more sensitive than healthy cells, reducing, therefore, the undesired side effects present in conventional approaches.

http://www.nocanther-project.eu/